Interleukin-2 in Treating Patients With Metastatic Melanoma

Clinical trial NCT00002845 · UNKNOWN

Trial details

NCT number: NCT00002845
Sponsor: Blumenthal Cancer Center at Carolinas Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1995-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.